D Abigerges
Impact in
- Oncology top 5%
- Neutropenia and Cancer Infections
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
Papers in
- Oncology 5
- Neutropenia and Cancer Infections 2
- Cancer Treatment and Pharmacology 1
- Lung Cancer Research Studies 1
-
- Cancer therapeutics and mechanisms 7
- Co-authors
- Patrice Herait (7 shared papers)Guy G. Chabot (6 shared papers)Jean‐Pierre Armand (8 shared papers)Daniel Gandía (4 shared papers)Alain Gouyette (1 shared paper)Marcel De Forni (4 shared papers)P. Armand (3 shared papers)Roland Bugat (3 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)European Journal of Cancer (3 papers)Annals of Oncology (2 papers)Anti-Cancer Drugs (1 paper)Journal of Thrombosis and Haemostasis (1 paper)
- Partner nations
- FranceGermanyNetherlands
In The Last Decade
D Abigerges
13 papers receiving 964 citations
Peers
Comparison fields: 5 of 69
- Oncology 560
- Toxicology 46
- Internal Medicine 29
- Molecular Biology 595
- Hepatology 50
Countries citing papers authored by D Abigerges
This map shows the geographic impact of D Abigerges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Abigerges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Abigerges more than expected).
Fields of papers citing papers by D Abigerges
This network shows the impact of papers produced by D Abigerges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Abigerges. The network helps show where D Abigerges may publish in the future.
Co-authors
The 25 scholars most cited alongside D Abigerges, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 268 | |
| 2 | 1994 | 227 | |
| 3 | 1995 | 160 | |
| 4 | 1995 | 103 | |
| 5 | 1993 | 97 | |
| 6 | 1997 | 49 | |
| 7 | 2018 | 32 | |
| 8 | 1996 | 29 | |
| 9 | 1996 | 26 | |
| 10 | 1995 | 21 | |
| 11 | 1993 | 13 | |
| 12 | 1996 | 1 | |
| 13 | 1993 | 1 |
About D Abigerges
D Abigerges is a scholar working on Oncology, Molecular Biology, Internal Medicine, Emergency Medical Services and Genetics, having authored 13 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Neutropenia and Cancer Infections (2 papers), Synthesis and biological activity (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper), Glioma Diagnosis and Treatment (1 paper), Acute Lymphoblastic Leukemia research (1 paper), Cancer Treatment and Pharmacology (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Oncology (560 citations), Toxicology (46 citations), Internal Medicine (29 citations), Molecular Biology (595 citations) and Hepatology (50 citations). D Abigerges has collaborated with scholars based in France, Germany and Netherlands. Frequent co-authors include Patrice Herait, Guy G. Chabot, Jean‐Pierre Armand, Daniel Gandía, Alain Gouyette, Marcel De Forni, P. Armand, Roland Bugat, Élie Fadel and Monder Mahjoubi. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, Anti-Cancer Drugs and Journal of Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.